130 related articles for article (PubMed ID: 35485859)
1. Melanin-Targeted PET Imaging With 18F-PFPN for Identifying Gastric Metastatic Melanoma.
Zhang X; Li M; Lan X
Clin Nucl Med; 2022 Jul; 47(7):666-667. PubMed ID: 35485859
[TBL] [Abstract][Full Text] [Related]
2.
Zhang X; Li M; Gai Y; Chen J; Tao J; Yang L; Hu F; Song W; Yen TC; Lan X
J Nucl Med; 2022 Oct; 63(10):1537-1543. PubMed ID: 35115367
[No Abstract] [Full Text] [Related]
3. Melanin-targeted [
Zhang X; Lin Z; Li M; Gai Y; Zheng H; Fan L; Ruan W; Hu F; Chen J; Lan X
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3062-3071. PubMed ID: 37191681
[TBL] [Abstract][Full Text] [Related]
4. Melanin-targeted [
Zhang X; Kang F; Zheng H; Gai Y; Wang J; Lan X
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):196-201. PubMed ID: 37714979
[TBL] [Abstract][Full Text] [Related]
5. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
6. Melanin-Targeted PET Imaging Sheds Light on Pigment Epithelioma in Corpus Ciliare.
Zhang X; Li M; Hu F; Lan X
Clin Nucl Med; 2022 Sep; 47(9):839-840. PubMed ID: 35930712
[TBL] [Abstract][Full Text] [Related]
7.
Wang Y; Li M; Zhang X; Ji H; Wang W; Han N; Li H; Xu X; Lan X
Mol Pharm; 2023 Jan; 20(1):572-581. PubMed ID: 36382713
[TBL] [Abstract][Full Text] [Related]
8. Malignant Melanoma of Glans Penis: Findings on 18F FDG PET/CT.
Sachani H; Tripathy S; Shamim SA; Rastogi S; Baa AK
Clin Nucl Med; 2021 Dec; 46(12):994-995. PubMed ID: 34392284
[TBL] [Abstract][Full Text] [Related]
9. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Prognostic Value of
Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival Melanoma on 18F-FDG PET/CT as a Second Primary Cancer.
Tsai SY; Shiau YC; Wang SY; Wu YW
Clin Nucl Med; 2016 Mar; 41(3):237-8. PubMed ID: 26646997
[TBL] [Abstract][Full Text] [Related]
12. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
13. Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data.
Reinhardt MJ; Kensy J; Frohmann JP; Willkomm P; Reinhold U; Grünwald F; Biersack HJ; Bender H
Nuklearmedizin; 2002 Jun; 41(3):143-7. PubMed ID: 12109034
[TBL] [Abstract][Full Text] [Related]
14. Solitary subcutaneous gouty nodule mimicking metastatic melanoma on FDG PET/CT.
Edwards KW; Doss M; Huang M; Hayes SB; Walia R; Yu JQ
Clin Nucl Med; 2015 Jun; 40(6):523-5. PubMed ID: 25608170
[TBL] [Abstract][Full Text] [Related]
15. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
16. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma.
Povoski SP; Hall NC; Martin EW; Walker MJ
World J Surg Oncol; 2008 Jan; 6():1. PubMed ID: 18186915
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
18. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma.
Kumar R; Alavi A
Curr Opin Oncol; 2005 Mar; 17(2):154-9. PubMed ID: 15725921
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT.
Fang N; Wang YL; Zeng L; Wu ZJ; Cui XJ
Clin Nucl Med; 2016 Feb; 41(2):e123-4. PubMed ID: 26053714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]